Display options
Share it on

Clin Liver Dis (Hoboken). 2015 Mar 27;5(2):39-42. doi: 10.1002/cld.448. eCollection 2015 Feb.

Hepatitis B reactivation from immunosuppressive drug therapy: A global menace.

Clinical liver disease

Robert P Perrillo

Affiliations

  1. Hepatology Division Baylor University Medical Center and University of Texas Southwestern Dallas TX.

PMID: 31040946 PMCID: PMC6490453 DOI: 10.1002/cld.448

[No abstract available.]

References

  1. MMWR Recomm Rep. 2008 Sep 19;57(RR-8):1-20 - PubMed
  2. Hepatology. 2009 Sep;50(3):661-2 - PubMed
  3. Gastroenterology. 1991 Jan;100(1):182-8 - PubMed
  4. Arthritis Care Res (Hoboken). 2010 May;62(5):704-11 - PubMed
  5. J Clin Oncol. 2010 Jul 1;28(19):3199-202 - PubMed
  6. J Clin Oncol. 2011 Aug 20;29(24):3270-7 - PubMed
  7. Antivir Ther. 2011;16(7):969-77 - PubMed
  8. South Med J. 2011 Dec;104(12):781-8 - PubMed
  9. J Hepatol. 2012 Jul;57(1):167-85 - PubMed
  10. J Clin Oncol. 2012 Sep 10;30(26):3167-73 - PubMed
  11. Semin Liver Dis. 2013 May;33(2):167-77 - PubMed
  12. JAMA. 2013 Oct 23;310(16):1664 - PubMed
  13. J Viral Hepat. 2015 Mar;22(3):346-52 - PubMed
  14. Gastroenterology. 2015 Jan;148(1):221-244.e3 - PubMed
  15. Hepatol Int. 2012 Jun;6(3):531-61 - PubMed
  16. Am J Epidemiol. 1987 Sep;126(3):484-91 - PubMed

Publication Types